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A B S T R A C T
The conversion of aqueous dispersion of nanostructured lipid carriers (NLCs) into dry powder
by spray drying could be a useful approach to render NLCs with better physical chemical
stability than the aqueous dispersion. In this study, aqueous NLC dispersion containing
fenofibrate was converted into dry, easily reconstitutable powder using spray drying.A central
composite face centered design (CCFD) was used to investigate the influence of the ratio
of lipid to protectant (mannitol and trehalose) and crystallinity of spray-dried powder on
the particle size, yield and residual moisture content of the dried powder. A linear rela-
tionship (R2 = 0.9915) was established between the crystalline content of the spray-dried
powders against the ratio of mannitol to trehalose from 3:7 to 10:0 (w/w). Spray drying of
NLC aqueous dispersion using a mannitol and trehalose mixture resulted in an increase
in particle size of the NLCs after reconstitution in water as compared to that in the initial
aqueous dispersion. The decrease in crystallinity of the dry powder by reducing the ratio
of mannitol to trehalose could improve the reconstitution of the NLCs in water. However
the yield and residual moisture content of dry powder decreased with an increase in the
ratio of mannitol to trehalose. Lipid nanoparticles were able to retain the drug incorpora-
tion and the prolonged drug release profile after spray drying.The experimental model was
robust, and suggested that spray drying is a viable technique for the conversion of NLCs
into dry powder.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical
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Lipid nanoparticles, solid lipid nanoparticles (SLNs) and
nanostructured lipid carriers (NLCs), are innovative drug
carrier systems which are composed of biocompatible
and biodegradable solid/liquid lipids as a matrix. These lipid
nanoparticles have a broad field of application[s] including
improving oral bioavailability [1,2] and dermal drug delivery
[3].
The lipid nanoparticles are often prepared in aqueous
phase. The lipids and drug are first melted and then dis-
persed in hot water containing surfactants to form an emulsion
by high-pressure homogenization or the sonication method.
The hot emulsion is finally cooled down to solidify the melted
lipid particles. During this process, the supercooled melts of
lipid-containing drugs are usually first formed and subse-
quent crystallization of lipids will take place during storage
[4,5]. The major drawback related to the SLNs and NLCs are
their physico-chemical instability, such as particle growth,
unpredictable gelation, drug expulsion during storage or un-
expected dynamic polymorphic transitions of the lipid particles
[6–13].
The conversion of the aqueous dispersion of lipid
nanoparticles into a dry powder is very useful and necessary
for improving stability. The aqueous dispersions can be trans-
formed by spray drying into a dry, fine, reconstitutable powder
that can be stored over a long period [14]. The dried powder
can be easily further converted into final products, such as
tablets or capsules. Spray-drying is widely used in the phar-
maceutical industry. The feed, e.g. aqueous solution or
suspension, is atomized in a hot gas stream and dried fast to
form solid microparticles. Carbohydrate excipients, such as
mannitol or trehalose, are often added and serve as protectants
or bulking agents that enable production of stablemicroparticles
with nanoparticles entrapped in the microparticle matrix to
provide the nanoparticles some degree of protection [15,16].
These carbohydrates are dissolvable in water, thus the
nanoparticles can be reconstituted [17,18].
The properties of the spray-dried product, such as yield,
moisture content and particle size after redispersion in water,
may be affected by the process parameters including the
concentrations of the lipid nanoparticles and the carbohy-
drates. The crystallization tendency of the carbohydrates also
has potential influence on the particle formation [19],
redispersity [20] of the spray dried particles. Optimization of
these parameters involves evaluation of a large number of
variables, which is often time-consuming and expensive. The
use of design of experiments (DOE) in such scenarios can
dramatically reduce the number of experiments without com-
promising the quality of the final product.The central composite
face centered design (CCFD) is one of the most widely used
designs that efficiently evaluates the influence of several vari-
ables on investigated responses. CCFD is a flexible design
which analyzes all the factors at three levels and has a high-
quality prediction in the entire design space [21–23]. Several
studies have been performed for NLCs and their solidifica-
tion using freeze drying; however, limited research is available
regarding the transformation of NLCs into solid powder using
spray drying.
In this study fenofibrate was used as a model drug.
Fenofibrate is mainly used for primary hypercholesterolemia
or mixed dyslipidemia.The oral absorption of fenofibrate is poor
due to poor water solubility [24]. Our previous study showed
that the oral absorption of fenofibrate could be improved by
NLC [25]. However, the NLC suspension is physically unstable
for long-term storage [10]. To improve the storage stability, the
fenofibrate loaded NLCs were transformed into dry powder by
spray drying. Mannitol and trehalose were selected to formu-
late with NLCs as they have been commonly used as drying
protectants for nanoparticles or proteins in the freeze drying
process [26] and spray drying process [16,22]. Mannitol is known
to result in a crystalline material after the spray drying process,
while trehalose is an amorphous material after spray drying.
However, to which degree the crystallinity of these protectants
in a drying formulation will influence the reconstitution of
nanoparticles has not been fully understood. In the present
study, we adjusted the crystallinity of spray dry powder by
varying the ratio of mannitol to trehalose in the formulation.
The effects of the crystallinity of the powder and lipid content
on the reconstitution of NLCs after the spray drying process
were investigated by using a DOE approach.
2. Materials and methods
2.1. Materials
Fenofibrate (purity ≥ 99%) was purchased from Sigma-Aldrich
(Germany). Glycerol Monostearate (40~55) (GMS), Sodium Lauryl
Sulfate (SLS) and Medium-Chain Triglyceride (MCT) were ob-
tained from Unikem (Copenhagen, Denmark). Poloxamer 407
(Lutrol F127) was obtained from BASF Aktiengesellschaft
(Germany). D(−)-Mannitol was obtained from VWR Interna-
tional Ltd. (England) and Trehalose was obtained from VVW
BDH Prolabo (Belgium).
2.2. Preparation of the NLCs
The NLCs were prepared according to our previous publica-
tion [10]. Briefly, weighed lipid mixture of GMS/MCT (1.25 g/
0.625 g) and drug (0.125 g) were melted in a water bath at 75
to 80 °C. The melting point of lipid component is about 60 °C
[10]. The drug-containing lipid melt was dispersed under con-
tinuous stirring in 20 ml hot aqueous surfactant solution of the
same temperature containing 3% Poloxamer 407 and 0.1% SLS
(w/v) under magnetic stirring to form an o/w emulsion. The
o/w pre-emulsion was treated with an ultrasonic probe (50/
60 KHz, 230V, Chemical Instruments AB, Sweden) at 80%
amplitude for 10 min with ultrasound burst of 2 s followed by
a 2 s pause. Finally, the formed o/w nanoemulsion was allowed
to cool down to room temperature to form nanostructured lipid
particles.
2.3. Conversion of the NLCs liquid dispersion into dry
product via spray drying
The lipid nanoparticles suspension was solidified using a BÜCHI
B-290 mini spray dryer (BÜCHI, Switzerland).Two-fluid nozzles
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were used with co-current flow and air as the drying medium
in an open cycle mode. The inlet temperature was main-
tained at 100 °C; the outlet temperature was maintained at 50
to 55 °C by adjusting the peristaltic pump rate (%). The drying
gas flow was maintained at 33 m3/h with an atomization gas
flow rate of 667 L/h. Sample solutions with 20% (w/w) solid
content were prepared with varying lipid-to-carbohydrate ratios
and mannitol-to-trehalose ratios. The nanoparticles suspen-
sion was feed in spray dryer at rate of 4~5 ml/min.
2.4. Characterization of NLC suspension and spray dried
powder
2.4.1. Particle size, particle size distribution and zeta
potential
The particle size, particle size distribution and zeta potential
of the NLCs in suspension were determined using a Zetasizer
Nano-ZS (Malvern Instruments, UK). The particle size was de-
termined as the mean hydrodynamic diameter (z-average) and
the particle size dispersion as the polydispersity index (PDI).
Measurements were performed at 25 °C. Samples were diluted
by Milli-Q water for 25 times prior to analysis.The Malvern DTS
v5.2 software was used for data acquisition and analysis. The
spray-dried powders were re-dispersed in Milli-Q water in a
concentration of 1% (w/v) by using a vortex for 30 s. The re-
constituted dispersion was again diluted 25 times before
analysis in a Zetasizer to obtain the particle size, polydisper-
sity index and zeta potential.
2.4.2. Entrapment efficiency and total drug content
Drug entrapment efficiency was determined indirectly by mea-
suring the total drug in the formulation and the free drug in
the aqueous phase of the nanoparticles dispersion [10]. The
free drug was separated from the formulation by using ultra-
filtration units along with centrifugation. Ultracentrifugal filter
(Amicon Ultra-0.5, Millipore) with a molecular weight cutoff
of 50 kDa was used.A 0.5ml lipid nanoparticles suspension was
accurately taken and placed into the upper chamber of the cen-
trifuge filter, which was centrifuged at 7000 rpm for 15 min at
room temperature. The ultrafiltrate was then analyzed using
HPLC as described later in this section. For the total drug
content, 0.5 ml of lipid nanoparticle suspension was accu-
rately taken and 4.5 ml acetone was added to it. The solution
was heated to 50 °C to ensure that the lipid and the drug were
completely dissolved in acetone.The solution was then cooled
down to room temperature and filtered using a 0.45 μm filter.
The filtrate was diluted 100 times with the mobile phase
and analyzed in HPLC as described later in this section.
The drug entrapment efficiency (EE %) can be calculated using







%( ) = − ×total 100 (1)
whereWfree: free drug in suspension; Wtotal: total drug amount
in suspension.
To measure the total drug content in the spray-dried NLCs,
0.260 mg of NLC powder, which contains fenofibrate equiva-
lent to the amount in 0.5 ml NLC dispersion, was weighed, and
0.5 ml of water and 4.5 ml of acetone were added to it.The dis-
persion was heated to 50 °C to extract fenofibrate from the lipid
nanoparticles.The dispersion was allowed to cool down to room
temperature and filtered using 0.45 μm filter. The filtrate was
diluted 100 times with the mobile phase and analyzed with
HPLC. The HPLC analysis was carried out on a Dionex HPLC
system (California, USA) and was analyzed using the soft-
ware Chromeleon 7.1. The analytical column used was the
Thermo analysis hypersil gold C18 column (5 μm, 150 × 4.6 mm).
Themobile phase was composed of methanol and water (80:20).
The flow rate was fixed at 1.0 ml/min and the detection was
performed at 288 nm using a UV-VIS detector.
2.4.3. In vitro drug release study
The drug-release study was performed using USP type 2 paddle
dissolution apparatus. 500 ml of 0.5% SLS was used as disso-
lution medium.The dissolution experiments were performed
at 37 ± 0.5 °C, with a paddle speed of 100 rpm. 2 ml of lipid
nanoparticles suspension, which is equivalent to 12.5 mg of
fenofibrate, was dispersed in dissolution medium. Samples of
0.4 ml were withdrawn at 5, 15, 30 min, 1, 2, 4, 6 and 8 h and
placed in a centrifugal tube with a 50 kDa molecular weight
cutoff, then centrifuged at 9000 rpm for 3 min.After every with-
drawal, the sample volume was replaced with 0.4 ml fresh
dissolution medium. Quantification of the ultrafiltrate samples
was done using the aforementioned HPLC method. The ex-
periments were performed in triplicate (n = 3).
The drug-release study from spray-dried NLC powders was
performed with the amount of spray-dried NLCs which con-
tains an amount of fenofibrate equivalent to the amount present
in 2 ml of an NLC dispersion. The experimental setup for the
drug-release study from spray-dried NLC particles was similar
to the drug-release study from NLC dispersion.
2.4.4. X-ray powder diffraction
The X-ray powder diffraction patterns were recorded using a
PANalytical X’Pert Pro diffractometer equipped with a PIXcel
detector (PANalytical X’Pert PRO MPD system, PW3040/60,The
Netherlands). Samples were placed on zero-background silicon
plates, and measured at ambient condition in reflection mode.
A continuous 2θ scan was performed in the range 5° to 45° with
a step size of 0.026° using Cu Kα radiation (λ = 1.5418 Å). The
voltage and current applied were 45 kV and 40 mA, respec-
tively.The scanning speed was 0.067° 2θ/s. Data were collected
using X’pert Data Collector software and analyzed using X’Pert
HighScore.
For the calculation of the degree of crystallinity a whole-
pattern approach rather than a single-peak approach was used
to eliminate the effect of preferred orientation. The calcula-
tion relies on the division of the powder diffraction pattern into
three contributions: the crystalline part, the amorphous part
and the background.The background was determined by mea-
suring three empty zero-background silicon plates and averaging
the results; the three background patterns were essentially iden-
tical and consisted of weak intensity uniform across the 2θ
range. This averaged background was subtracted from all
powder patterns before further calculations, leaving powder
patterns consisting of only the crystalline and the amor-
phous signals. The amorphous part was distinguished from
the crystalline part by means of the Brückner algorithm [27],
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essentially a high-pass filter that separates the slowly fluctu-
ating background from the higher-frequency changes associated
with Bragg peaks and noise; we note that application of the
Brückner algorithm does not require the crystal structures of
the crystalline phases to be known. Because mannitol and tre-
halose have the same chemical composition, no further
corrections are needed and the degree of crystallinity can be
calculated directly as the ratio of the crystalline contribution
divided by the sum of the crystalline and the amorphous con-
tributions. The calculations were carried out in the Materials
Studio software [28].
2.4.5. Residual moisture content and yield
The residual moisture content in the spray-dried samples was
determined by Perkin ElmerTGA 7 (Perkin Elmer, USA) and Pyris
software.The samples were heated from 25 °C to 180 °C at 10 °C/
min in a dry nitrogen atmosphere at a nitrogen flow rate of
20 ml/min. The moisture content was then calculated by the
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where SWb is the sample weight before heating and SWa is the
sample weight after heating.The yield was determined by cal-
culating the percentage of spray dried powder as compared to
the total amount of feed materials including drug, lipid, man-
nitol and trehalose that were used in the formulation.
2.4.6. Scanning electron microscope
The spray-dried samples were analyzed using a JEOL, JSM 5200
scanning electronmicroscope (JEOL Inc., MA, USA).The samples
were placed on aluminum probes and sputter coated with gold
using an Auto Sputter Coater E5200, Bio-Rad Polaron, and ob-
served under SEM at an accelerating voltage of 1 kV.The Atomic
Force Microscope (AFM) image was acquired by Multimode
NanoScope V system (Veeco Instruments Inc., Plainview, NY).
Samples were prepared by deposition of a 2 μl drop of a NLC
suspension onto freshly cleaved mica. Commercial silicon
nitride cantilevers, 100 μm in length, with a normal spring con-
stant 0.5 Nm−1, with integrated sharpened tips, were used.The
topographic profile was obtained by tipping mode in liquid with
a scan rate of 1–2 Hz.
2.5. Experimental design and statistical evaluation
A central composite face-centered design (CCFD) with 11 ex-
periments was developed for the optimization of solidification
of NLCs using spray drying, as shown in Table 1. The influ-
ence of variables such as ratio of lipid to total carbohydrate
content and ratio of mannitol to trehalose was investigated.
The responses were yield of powder (%), moisture content (%)
and particle size after re-dispersion of spray dried NLC. The
experiments were generated and analyzed by the software
MODDE 9.1 (Umetrics AB, Sweden).The significance of themodel
was determined by analysis of variation (ANOVA). The re-
sponses of the model, Y1 = Particle size, Y2 = Yield and
Y3 = Moisture content, were modeled using the following poly-
nomial quadratic equation.
Y = + + + + +b b X b X b X X b X X b X X0 1 1 2 2 3 1 1 4 2 2 5 1 2 (3)
where b1 and b2 are the linear coefficients, b3 and b4 are the
quadratic coefficients and b5 is the interaction coefficient
between the two factors X1 and X2. The results were analyzed
by ANOVA, which determined if the factors and the interac-
tions were significant or not on a 95% significance level. The
dissolution profiles were compared using two-way ANOVA and
post test Bonferroni with multiple comparisons using the soft-
ware GraphPad Prism 5 (GraphPad Software, Inc.).
3. Results and discussion
3.1. Crystallinity content of carbohydrates in the spray-
dried powder
The crystallinity content of the protectant in the spray-dried
powdermay affect the particle size andmoisture content of the
sprayed powder.Thus in this section, the relationship between
degree of crystallinity and the content of mannitol was estab-
lished.Thisdegreeof crystallinitywasdeterminedexperimentally
by co-spray drying mannitol and trehalose solutions with six
different ratios, and calculating the degree of crystallinity from
the XRPD pattern.As shown in Fig. 1, a good linear relationship
(R2 = 0.9915) could be established between the crystalline content
(%) against the mannitol content (%) from 30% to 100%.
Table 1 – CCFD of experiments and its responses.
Exp. name Run order Lipid content (%) Mannitol content (%) Particle size (nm) Moisture content (%) Yield (%, w/w)
N1 9 5 50 1255 3.7 15.7
N2 8 20 50 2219 2.8 26.6
N3 4 5 100 1417 0.4 9.4
N4 5 20 100 3588 0.7 5.4
N5 10 5 75 1942 2.0 3.9
N6 7 20 75 5123 2.0 0.9
N7 1 12.5 50 4945 2.9 15.7
N8 11 12.5 100 2022 0.8 3.1
N9 3 12.5 75 2088 1.9 6.3
N10 2 12.5 75 2417 2.7 6.8
N11 6 12.5 75 2256 2.6 6.4
Note: Central point repetition tests = 3; The variation of these repetition test results are: standard deviation for Particle size = 164 nm; stan-
dard deviation for Moisture content = 0.4 %; standard deviation for Yield = 0.3%.
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3.2. Optimization of spray drying using CCFD
3.2.1. Statistical analysis and fitted polynomial equation of
CCFD
Based on the linear relationship between degree of crystallin-
ity against mannitol content, approximately 75% mannitol
(which corresponds to a 75:25 mannitol to trehalose ratio) was
used as the midpoint to design a set of experiments in which
the mannitol content was varied from 50% to 100%.The lipid-
to-carbohydrate ratio was varied from 5:95 to 20:80 maintaining
the total solid concentration at 20% (w/v). A CCFD with 11 ex-
periments was set up to investigate the influence of crystalline
content and lipid content on yield, moisture content and the
particle size after redispersion of the spray-dried NLC.The CCFD
of experiments and its responses are shown in Table 1.
ANOVA was performed on the experimental data to evalu-
ate the significance and validity of the model. As shown in
Table 2, the model was significant for all responses with good
regression coefficients.The predictive power (Q2) was very good
(>0.5) for particle size and moisture content, but was below the
reference for yield (0.3545). The particle size and moisture
content fitted well with a significance level of 95%, but the yield
showed a lack of fit on a confidence level of 95%.The fitted poly-
nomial equations for all the responses were constructed by
generating the scaled and centered coefficients in MODDE 9.1,
which are shown in Table 3.The contour plots for particle size,
moisture content and yield are shown in Fig. 2. These poly-
nomial equations allow us to evaluate the effect of the
investigated factors and predict the responses to obtain the
optimal process parameters.
3.2.2. Particle size after redispersion in water
The coefficients (b1 to b4) were statistically significant (p value
<0.05). The significant and positive values of the coefficients
indicate that the particle size of the redispersed NLC system
significantly increases with an increase in lipid content and
mannitol content (Fig. 2). The potential explanation for this is
that carbohydrates can form a thick protective layer around
the lipid nanoparticles which protects them against the me-
chanical stress and heat stress during spray drying.When the
lipid content increases, the corresponding amount of carbo-
hydrate present decreases and is insufficient to protect the lipid
nanoparticles against the stress during spray drying, which
could increase the tendency of particle aggregation, thus causing
an increase in particle size [14,29]. It can also be observed that
when the mannitol content is increased from 50% to 100%, the
particle size also increases significantly. Similar results have
been reported before where trehalose showed better
redispersion and better retention of the particle size of origi-
nal dispersion than mannitol [14]. From the powder diffraction
patterns in our study, the crystalline content of the formula-
tions increased significantly up to 62% when increasing the
Fig. 1 – (a) X-ray powder diffraction patterns showing an increase in crystalline phase with an increase in the mannitol
content in the formulation: red line: 50% mannitol; blue line: 75% mannitol; green line: 100% mannitol; (b) Linear
relationship between mannitol content (%) and crystalline content (%) (R2 = 0.9915).
Table 2 – Model performance indicators and ANOVA analysis results for the investigated responses for spray drying NLC.
Model performance indicator Reference value
for good model
Investigated responses
Particle size (nm) Moisture Content (%) Yield (%, w/w)
Regression coefficients(R2) Close to 1 0.9850 0.9466 0.8811
Difference (R2−Q2) <(0.2–0.3) 0.0428 0.199 0.5266
Goodness of prediction (Q2) >0.5 0.9422 0.7470 0.3545
Model validity >0.25 0.8978 0.9292 −0.2000
Reproducibility >0.5 0.9601 0.8379 0.9987
ANOVA Significance of regression model (p-value) <0.05 0.001 0.001 0.006
Lack of fit test (p-value) >0.05 0.665 0.754 0.004a
a Non-significant coefficient contributions.
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mannitol content from 50% to 100%. The increase in particle
size could be due to the poor wetting ability of the crystalline
phase compared to the amorphous phase [30]. With increas-
ing mannitol content, the particles were dispersed with more
difficulty in water, leading to insufficient breakdown of par-
ticle aggregates. In addition, the higher amount of mannitol
increased the crystallization tendency of the spray dried powder.
The mechanical forces exerted in the crystallization of man-
nitol may lead to fusion of NLCs as a result of failure to protect
nanoparticle from agglomeration.
Freeze-drying is another technique to improve stability of
colloidal nanoparticles. The high concentration of particulate
system and the crystallization of ice may also induce aggre-
gation and in some cases irreversible fusion of nanoparticles,
leading to its destabilization. For these reasons, cryoprotectants
and/or lyoprotectant must be added to the suspension of
nanoparticles before freezing drying to protect nanoparticles
[26]. Trehalose is also proved to be most effective in prevent-
ing nanoparticle growth during freeze-drying process. Changes
in particle size during lyophilization could be minimized by
optimizing the parameters of the lyophilization process [31],
whereas some solid lipid nanoparticles (SLN), such as SLN con-
taining hydrocortisone and progesterone complexes with
β-cyclodextrins, could be freeze-dried without the addition of
cryoprotectants [32]. The freeze-drying is cost intensive and
time-consuming compared with spray drying.
The powder obtained by freeze-drying has a loose struc-
ture, while spray drying generates powder with better flow
property. It was observed in this study that the spray-dried
product flowed more freely when the proportion of trehalose
in the feed solution was increased. However, we failed to explain
the mechanism. The difference in particle size of spray dried
powder would be an explanation, as flow properties of powder
are known to be influenced by particle size.We speculate that
when trehalose was used as a protectant, the particles would
have relative larger particle size than that of mannitol used,
because the spray dried trehalose particle is in amorphous state
and has a lower density than that of crystalline material.
However, we did not observe a distinct difference in particle
sizes of spray dried powder containing mannitol or trehalose
under SEM.The difference in flow properties could also be at-
tributed to other factors such as electrostatic interactions and
surface chemistry. However they were not investigated in the
current study. Nevertheless we speculate there was more lipid
presenting on the surface of the particles made of mannitol.
It could be due to the fact that crystallization of mannitol
‘squeezed’ lipid to the surface of the particles, resulting in fusion
of particles and making the particles sticky.
3.2.3. Moisture content
After investigation of the fitted polynomial equation for re-
sponse variable Y2 (moisture content), only linear coefficient
b2 is significant with a high regression coefficient (R2 = 0.9466).
The significance of coefficient b2 and the high predictive power
(Q2 = 0.7470) suggest that the moisture content is only signifi-
cantly influenced by the ratio of mannitol to trehalose, as shown
in Fig. 2, while the effect of lipid content on the moisture
content is not significant. When the mannitol content is in-
creased from 50% to 100%, the residual moisture content in
Table 3 – Scaled and centered coefficients of the
investigated responses for the polynomial equation (3).
Polynomial equation for the selected model
Yi = constant + b1 × X1 + b2 × X2 + b3 × X12 + b4 × X22 +
b5 × X1 × X2.








Constant 2281.15 2.30226 4.864
b1 x1 1053.86 −0.113833a 0.680833a
b2 x2 703.504 −1.25817 −6.69917
b3 x1 × x1 632.431 −0.174658a 7.78183
b4 x2 × x2 −1063.94 −0.295657a b
b5 x1 × x2 b 0.30725a −3.71625a
a Non-significant coefficient contributions.
b Missing values indicate removal of the term during model
refinement.
Fig. 2 – Contour plots for particle size, moisture content and yield. The particle size of the redispersed NLC system
significantly increases with an increase in lipid content and mannitol content. The moisture content is only significantly
influenced by the ratio of mannitol to trehalose. The yield decreases with an increase in the mannitol content.
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the spray-dried product decreased significantly from 3.7% to
0.4%. This could be explained by the lower hygroscopicity of
the crystalline phase of mannitol compared to the amor-
phous phase [33]. Therefore, it can be concluded that a low
moisture content can be maintained by using a sufficient
amount of mannitol.
3.2.4. Yield
The model fitted for the response yield (Y3) was found to be
significant with a regression coefficient value of 0.8811, as
shown in Table 2. The predictive power of the model is very
low (0.3545), showing lack of fit on a significance level of 95%.
Further investigation of the fitted polynomial equation for the
yield showed that the only statistically significant regression
coefficients were b2 and b3 (Table 3). The negative value for the
linear regression coefficient b2 indicates that with the in-
crease in the mannitol content, the yield decreases; this can
also be observed in the contour plots of Fig. 2. A possible reason
behind this could be the formation of sticky and less free
flowing powder with increasing content of mannitol prob-
ably due to electrostatic interactions.A spray-dried formulation
with 100% mannitol yielded particles that were sticking to the
walls of the drying chamber, the cyclone and the collection
vessel because of van der Waals force or electrostatic adher-
ence. The results indicate there is no significant influence of
the lipid content on the yield, which may be attributed to the
large percentage of carbohydrate in the formulation. The ma-
terial property of the spray dried powder is dominated by
carbohydrate.
3.3. Optimized formulation and characterization of
optimized spray dried NLC
After analyzing and validating the design, an optimizer was
used to predict a combination of investigated factors that would
result in an optimal product [34]. Here, the responses were speci-
fied according to the experimental goals i.e., maximum yield
(>50%), minimal particle size (500 nm) and minimal moisture
content (<1.0%). Different combinations of factors were gen-
erated by the optimizer, but none of them could meet the
desirable values for all the responses. So, considering par-
ticle size and yield as the primary concern, factor combinations
from the optimizer were selected that would meet optimal re-
sponses for yield and particle size which is shown in a sweet
spot plot in Fig. 3, where the green region indicates the sweet
spot.
To validate the experimental model, experiments in the
sweet spot with 13% lipid content and 50% mannitol content
were performed in triplicate (n = 3), and were compared with
the predicted value. The predicted response and the ob-
tained experimental results are shown in Table 4. Two sample
t-tests (α = 0.05) showed that there was no significant differ-
ence between the observed and the predicted values for all the
responses, confirming that themodel is robust.The results from
this optimization study showed the possibility of regulating the
characteristics of a spray-dried powder by altering the inves-
tigated factors.
The particle size (z-average, nm) of freshly prepared NLCs
was 98 ± 1 nm. The entrapment efficiency of NLC was deter-
mined about 99.8% due to the high affinity of drug to α-form
of lipid [10,25].The total fenofibrate content in 260 mg of spray
dried NLC was measured to be 5.52 mg. A two sample Stu-
dent’s t-test showed that the difference between amount of
fenofibrate present in 260 mg of spray dried NLC and 0.5 ml
of NLC dispersion was insignificant (p = 0.60).This indicates that
spray drying NLC is able to retain the incorporated drug in it.
This is probably because of the lipophilic nature of the drug
which facilitates the retention of the drug in the lipid matrix
even during spray drying.The NLCs have a spherical shape ob-
served by atomic force microscopy, as shown in Fig. 4a. The
spray-dried powder shows irregular shapes with particle sizes
ranging from 10 to 100 μm (Fig. 4b).
The in vitro drug-release profile of NLC dispersion before and
after spray drying is shown in Fig. 5.Although a two wayANOVA
showed that after spray drying the release profile has been
slightly changed (p = 0.0235), a prolonged drug release was still
observed, showing a possibility of maintaining sustained drug
release from NLCs even after conversion to dried powder. Our
previous study showed that the dominant factors affecting the
drug release profiles could be the nature of lipid matrix, which
was influenced by the transformation of lipid crystalline struc-
ture. The crystalline form of freshly prepared lipid particles is
α-form with drug well entrapped [10]. The crystalline form of
lipid may be partly changed from α-form to a more rigid β-form
by heat stress during spray drying, leading to expulsion of drug
Fig. 3 – Sweet spot plot showing the optimal region where
the green region indicates the sweet spot.
Table 4 – Predicted and observed results for the









Predicted results 3.2 ± 0.6 586 ± 332 19.6 ± 4.7
Spray dried NLC with drug 3.3 ± 0.5 736 ± 105 16.7 ± 1.5
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out of lipid nanoparticles during this crystalline transforma-
tion [10]; however, our XRPD result was not able to prove this
speculation due to the shielding by mannitol crystals. Another
possible reason could be due to the fact the fusion of lipid par-
ticles during the spray drying process may expel some drug
to the surface of the particles.
4. Conclusion and future perspective
This study demonstrated spray drying as a viable method to
solidify NLCs to a powder form. A CCFD was constructed to
investigate the influence of lipid-to-carbohydrate ratio and
mannitol-to-trehalose ratio on the characteristics of the re-
sultant product such as yield, residual moisture content and
the particle size after redispersion. The results from the sta-
tistical analysis andmathematical modeling of the experimental
design indicated that both lipid and mannitol content signifi-
cantly influenced the particle size after redispersion. However,
the residual moisture and the yield were only significantly in-
fluenced by the mannitol-to-trehalose ratio.The experimental
model is robust as no significant difference was seen between
observed and predicted responses for the optimal formula-
tion. These results suggest that spray drying is a suitable
technique for conversion of NLCs into dry powder, and that
manipulation of some crucial factors can result in the desired
formulation. Moreover, the statistical design has shown use-
fulness in the optimization process, and this study might serve
as groundwork for the further understanding of the solidifi-
cation of NLCs.
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